Laura Polito

Dr. Laura Polito

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2006 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
CNChristian Noti
Christian Noti
José L. De PazJosé L. De Paz
José L. De Paz
LPLaura Polito
Laura Polito
PSPeter Seeberger
Peter Seeberger

1 November 2007 in ACS Chemical Biology
Verified
Journal Article
Closed access
José L. De PazJosé L. De Paz
José L. De Paz
EME. Ashley Moseman
E. Ashley Moseman
CNChristian Noti
Christian Noti
LPLaura Polito
Laura Polito
UAUlrich H. von Andrian
Ulrich H. von Andrian
PSPeter Seeberger
Peter Seeberger

Verified
Journal Article
Open access
PDF file
CKClaudia Kohout
Claudia Kohout
CSCristina Manuela Santi
Cristina Manuela Santi
LPLaura Polito
Laura Polito
Gold nanoparticles (AuNPs) play a crucial role in the development of nanomedicine, principally due to their unique photophysical properties and high biocompatibility. The possibility to tune and customize the localized surface plasmon resonance (LSPR) toward near-infrared region by modulating the AuNP shape is one of the reasons for the huge widespread use of AuNPs. The controlled synthesis of no-symmetrical nanoparticles, named anisotropic, is an exciting goal achieved by the scientific community which explains the exponential increase of the number of publications related to the synthesis and use of such type of AuNPs. Even with such steps forward and the AuNP translation in clinic being done, some key issues are still remain and they are related to a reliable and scalable production, a full characterization, and to the development of nanotoxicology studies on the long run. In this review we highlight the very recent advances on the synthesis of the main classes of anisotropic AuNPs (nanorods, nanourchins and nanocages) and their use in the biomedical fields, in terms of diagnosis and therapeutics.

1 December 2020 in Drug Discovery Today: Technologies
Verified
Journal Article
Open access
RFRuth Mateu Ferrando
Ruth Mateu Ferrando
LLLuigi Lay
Luigi Lay
LPLaura Polito
Laura Polito
Since their discovery, therapeutic or prophylactic vaccines represent a promising option to prevent or cure infections and other pathologies, such as cancer or autoimmune disorders. More recently, among a number of nanomaterials, gold nanoparticles (AuNPs) have emerged as novel tools for vaccine developments, thanks to their inherent ability to tune and upregulate immune response. Moreover, owing to their features, AuNPs can exert optimal actions both as delivery systems and as adjuvants. Notwithstanding the potential huge impact in vaccinology, some challenges remain before AuNPs in vaccine formulations can be translated into the clinic. The current review provides an updated overview of the most recent and effective application of gold nanoparticles as efficient means to develop a new generation of vaccine.

24 May 2017 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
Federica CompostellaFederica Compostella
Federica Compostella
OPOlimpia Pitirollo
Olimpia Pitirollo
ASAlessandro Silvestri
Alessandro Silvestri
LPLaura Polito
Laura Polito
Glyco-gold nanoparticles combine in a single entity the peculiar properties of gold nanoparticles with the biological activity of carbohydrates. The result is an exciting nanosystem, able to mimic the natural multivalent presentation of saccharide moieties and to exploit the peculiar optical properties of the metallic core. In this review, we present recent advances on glyco-gold nanoparticle applications in different biological fields, highlighting the key parameters which inspire the glyco nanoparticle design.

4 December 2007 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
LPLaura Polito
Laura Polito
DMDiego Monti
Diego Monti
ECEnrico Caneva
Enrico Caneva
EDEleonora Delnevo
Eleonora Delnevo
GRGiovanni Russo
Giovanni Russo
Davide ProsperiDavide Prosperi
Davide Prosperi
We have developed an efficient conversion of amino iron oxides to carbohydrate and protein derived nanoparticles with highly conserved bioactivity through a combination of diazo transfer and azide–alkyne click technology.